about
Revised timeline and distribution of the earliest diverged human maternal lineages in southern AfricaTargeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour developmentGenetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil)Clinical presentation of prostate cancer in black South AfricansComplex patterns of genomic admixture within southern AfricaA common human leucocyte antigen-DP genotype is associated with resistance to HIV-1 infection in Kenyan sex workers.Mitochondrial mutations and metabolic adaptation in pancreatic cancer.Identification of four novel KIR2DL2 alleles and two novel KIR2DL3 alleles in an East African population.Human leukocyte antigen-DQ alleles and haplotypes and their associations with resistance and susceptibility to HIV-1 infection.Longitudinal study of user experiences of a CPOE system in a pediatric hospital.Delivering safe and effective test-result communication, management and follow-up: a mixed-methods study protocol.Compliance with pathology testing guidelines in Australian general practice: protocol for a secondary analysis of electronic health record dataExtracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate CancerDiversity and Frequencies of HLA Class I and Class II Genes of an East African PopulationInteraction and innovation: practical strategies for inclusive consumer-driven research in health servicesDiagnostic Informatics: Its Role in Enhancing Clinical Excellence, Patient Safety and the Value of Care
P50
Q28651584-FAE3BBC8-DB63-4DB8-A4F4-CD60B75AC8A4Q28831339-CCA47614-E6F8-4EEC-B490-6B09315235B5Q33944213-A84309C9-75D8-4446-B81E-17C73F0E7938Q34054169-4A101AEC-1368-49BD-A3EF-1DB8B8B50395Q34629194-8340C64F-B640-43FA-A0B2-0173ADD03BE7Q37195256-944AA0B3-DBAC-4ACA-A14D-EBDC2C837DF2Q37615978-59C7ECFD-2FB6-425F-A979-0A2C88863E9DQ42875126-64487089-CB23-4D43-9806-149D787CC136Q48684309-1FE056BC-2039-4A95-BAC9-30BD715E62F2Q49361818-1D8E576D-1224-44E0-A420-BD4F214670BBQ49960922-43163B81-FDBA-4C65-BFF4-B793A849BCF5Q59808243-3AF4AED2-4A3D-4BC1-8A8F-E31F2C291C9AQ63372092-566A24BB-44A2-4164-B80C-60685DC95545Q63372129-A33A8C6C-9452-41EA-A145-5388479FCEB6Q92057270-6FBD2843-588E-4A59-93F4-75889CC7773FQ92779069-EAD7497B-5AF4-49F9-85E3-8F429A9D4541
P50
description
researcher, ORCID id # 0000-0003-4868-4045
@en
wetenschapper
@nl
name
Rae-Anne Hardie
@ast
Rae-Anne Hardie
@en
Rae-Anne Hardie
@es
Rae-Anne Hardie
@nl
type
label
Rae-Anne Hardie
@ast
Rae-Anne Hardie
@en
Rae-Anne Hardie
@es
Rae-Anne Hardie
@nl
prefLabel
Rae-Anne Hardie
@ast
Rae-Anne Hardie
@en
Rae-Anne Hardie
@es
Rae-Anne Hardie
@nl
P106
P1153
53363556800
57195298923
P21
P31
P496
0000-0003-4868-4045